| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NextCure, Inc. | President & CEO, Director | Employee Stock Option (Right to Buy) | 244K | Mar 29, 2024 | Direct | ||
| PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 40K | Jun 21, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NXTC | NextCure, Inc. | Mar 29, 2024 | 1 | $0 | 4 | Apr 2, 2024 | President & CEO, Director |
| NXTC | NextCure, Inc. | Jan 31, 2024 | 1 | $0 | 4 | Feb 1, 2024 | President & CEO, Director |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| NXTC | NextCure, Inc. | Feb 28, 2023 | 1 | $0 | 4 | Mar 1, 2023 | President & CEO, Director |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| NXTC | NextCure, Inc. | Jan 31, 2022 | 1 | $0 | 4 | Feb 2, 2022 | President & CEO, Director |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |